Pre-Annual Meeting Seminars

ASCO will offer five in-depth educational opportunities dedicated to topics of interest in the oncology community. Each seminar will be held onsite at McCormick Place, from Thursday, May 28 to Friday, May 29. Seminar topics and preliminary program information can be found below.

Pre-Annual Meeting Seminars registration is now open. Register early and save on registration fees.

This seminar will take place in room S103 at McCormick Place, Chicago, IL.

The financing and organization of cancer care is shifting dramatically. Today, there is almost daily discussion among policymakers, providers, and payers regarding treatment costs and how best to reward provision of high-quality care. Innovative reimbursement models, treatment pathways, and benefits provide lessons learned and new best practices.Yet, the pace of innovation in these areas is rapid, and many stakeholders are likely affected by such changes including but not limited to payers, providers, and patients. This seminar provides participants with core and emerging knowledge regarding cost and quality drivers in cancer treatment development and provision. The goal of this seminar is to provide participants sufficient background knowledge to make better-informed decisions in their relations with patients and payers.

This seminar will cover current and innovative strategies for rewarding research and development in cancer therapeutics and diagnostics, trends in trial costs, drug pricing, financial burdens placed on patients, the basics of reimbursement and coverage decision-making, lessons from innovative reimbursement, coverage and treatment models, options for reimbursement reform, and defining quality in the outpatient setting.

Thursday, May 28, 2015

12:30 PM

1:00 PM

Boxed Lunch Provided

1:00 PM

2:20 PM

Session 1: Current and Future Strategies for Rewarding Research and Developement in Cancer Therapeutics and Diagnostics

Elad Sharon, MD, MPH — Session Chair, Planning Committee Member
National Cancer Institute at the National Institutes of Health

1:05–1:20 PM
Trends in Cancer Treatment Development and Spending Worldwide
Murray Aitken, MBA
IMS Institute for Healthcare Informatics 

1:20–1:35 PM
The Impact of Capital Markets on the Development of Novel Therapeutics and Diagnostics in Cancer
Joshua Bilenker, MD
Loxo Oncology, Inc.

1:35-1:50 PM
Pricing as an Incentive for Investment
David Howard, PhD
Emory University 

1:50-2:20 PM
Panel Discussion; and Question and Answer
Margaret M. Mooney, MD, MBA, National Cancer Institute at the National Institutes of Health; and Dr. Sharon

2:20 PM

2:40 PM

Break

2:40 PM

4:00 PM

Session 2: Spending on Cancer Care

K. Robin Yabroff, PhD, MBA — Session Chair, Planning Committee Member
National Cancer Institute at the National Institutes of Health

2:45-3:00 PM
National trends in Spending on Cancer Treatment
Dr. K. Robin Yabroff, PhD, MBA
National Cancer Institute at the National Institutes of Health 

3:00-3:15 PM
Trends in the Costs and Utilization of Targeted Cancer Therapies
Ya Chen Tina Shih, PhD
The University of Texas MD Anderson Cancer Center 

3:15-3:30
Cancer Diagnosis, Treatment and Work
Cathy J. Bradley, PhD
Virginia Commonwealth University 

3:30-4:00
Panel Discussion; and Question and Answer
Peter Bach, MD, MAPP, Memorial Sloan Kettering Cancer Center; and Dr. Yabroff 

Friday, May 29, 2015

7:00 AM

7:30 AM

Continental Breakfast Provided

7:30 AM

9:05 AM

Session 3: Innovative Reimbursement, Coverage and Treatment Models

Rena M. Conti, PhD — Session Chair, Planning Committee Chair​
The University of Chicago

7:35 AM – 7:50 AM
The Anthem Pathways Initiative
Jennifer Malin, MD, PhD
Anthem, Inc. 

7:50 AM –8:05 AM
Update on COME HOME, the Oncology Medical Home
Barbara L. McAneny, MD, FASCO
New Mexico Cancer Center 

8:05-8:20 AM
CMS -- Using an Episode Based Payment Model to Improve Oncology Care
Ron Kline, MD
Centers for Medicare & Medicaid Services 

8:20-9:05 AM
Panel Discussion; and Question and Answer
Jeff Ward, MD, Swedish Cancer Institute; and Dr. Conti

9:05 AM

9:30 AM

Break

9:30 AM

11:00 AM

Session 4: Future Reform

Mark McClellan, MD, PhD — Session Chair
Brookings Institute

9:35-9:50 AM
Ideal Cancer Payment Bundles: Resurrecting the Center for American Progress
Peter Bach, MD, MAPP
Memorial Sloan Kettering Cancer Center 

9:50-10:05 AM
Rethinking Drug Acquisition and Coverage
Mark McClellan, MD, PhD
Brookings Institute

10:05-10:20 AM
Cancer Outcome Measurement:  The Key to Paying for Value in Cancer Care
Thomas W. Feeley, MD
The University of Texas MD Anderson Cancer Center 

10:20-11:00 AM
Panel Discussion; and Question and Answer
Dan Todd, Todd Strategy

 


Disclosures

View Program Committee Disclosures

Continuing Medical Education Information

Economics of Cancer Care

This seminar will focus on current and innovative strategies for rewarding research and development in cancer therapeutics and diagnostics, trends in trial costs, drug pricing, financial burdens placed on patients, the basics of reimbursement and coverage decision-making, lessons from innovative reimbursement, coverage and treatment models, options for reimbursement reform, and defining quality in the outpatient setting.

2015 Annual Meeting General Accreditation Information

The American Society of Clinical Oncology (ASCO) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Annual Meeting has been approved for 39.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The total number of credits that may be earned from the Pre-Annual Meeting Seminar: Economics of Cancer Care  is  5.5 AMA PRA Category 1 Credits™.

All nonphysician attendees are welcome to submit a request for a Certificate of Participation, which may enable nonphysicians to apply their Annual Meeting participation toward re-licensure. Please note, however, that all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits were submitted.

Any questions related to CME may be directed to ASCO Staff at cme@asco.org.

Learning Objectives

Upon completion of this seminar, the learner should be able to:

  • Relate empirical facts and evidence regarding current trends in cancer care treatment development and delivery

including spending and quality of care.

  • Describe basic terminology and main challenges in the current cancer care payment and delivery systems.
  • Apply this knowledge to discussions of reform opportunities and challenges and to cancer care treatment decisions. 

Unlabelled Usage Statement

The information presented is that of the contributing faculty and does not necessarily represent the views of the American Society of Clinical Oncology and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information.